PremiumCompany AnnouncementsElutia Inc. Reports Strong Q3 Results, Prepares for Major Product Launch Elutia reports Q3 EPS (33c) vs (57c) last year ELUT Upcoming Earnings Report: What to Expect? PremiumThe FlyElutia price target raised to $10 from $5 at Lake Street Elutia price target raised to $11 from $5 at Cantor Fitzgerald Aziyo Biologics Gains FDA Clearance for EluPro® Bioenvelope PremiumThe FlyElutia management to meet virtually with Lake Street Elutia management to meet virtually with Lake Street New Innovation / R&D Risk for Aziyo Biologics, Inc. Class A – What’s the Latest? 
